Lakewood-Amedex Biotherapeutics Presents Data Highlighting Nu-3's Broad-Spectrum Antimicrobial Activity and Low Potential for Resistance at IDWeek 2026
Oct 21, 2026, 08:02 ET Research highlights Nu-3's rapid bactericidal activity against clinically relevant resistant pathogens and its potential as a topical treatment for infected diabetic foot ulcers Details of the presentation are as follows: Nu-3 – A Novel, Broad Spectrum Antimicrobial Compound…